Collplant Biotechnologies Stock Widgets and Gadgets
| CLGN Stock | USD 4.25 0.01 0.23% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- CLGN Collplant Biotechnologies
- Latest What To Expect From CollPlant Biotechnologies Ltd Q3 2024 Earnings
- CLGN 4.25 -0.01
- Low 3.51
- High 4.25
- Alpha -0.38
- Beta 1.22
- Return On Equity -0.62
- Return On Asset -0.34
- Operating Margin (17.69) %
- Current Valuation 36.55 M
- Shares Outstanding 11.45 M
- Shares Owned By Insiders 10.10 %
- Shares Owned By Institutions 12.23 %
- Number Of Shares Shorted 12.07 K
- Price To Earning 92.60 X
- Price To Book 2.88 X
- Price To Sales 70.63 X
- Revenue 10.96 M
- Gross Profit 13.64 M
- EBITDA (6.41 M)
- Net Income (7.02 M)
- Cash And Equivalents 36.29 M
- Cash Per Share 3.27 X
- Total Debt 3.16 M
- Debt To Equity 0.08 %
- Current Ratio 16.21 X
- Book Value Per Share 2.48 X
- Cash Flow From Operations (2.76 M)
- Short Ratio 0.70 X
- Earnings Per Share (1.53) X
- Target Price 12.5
- Number Of Employees 75
- Beta 0.48
- Market Capitalization 48.66 M
- Total Asset 34.13 M
- Retained Earnings (96.74 M)
- Working Capital 24.77 M
- Current Asset 17.03 M
- Current Liabilities 6.37 M
- Net Asset 34.13 M
- Accumulation Distribution 0.17
- Daily Balance Of Power (0.01)
- Rate Of Daily Change 1.0
- Day Median Price 3.88
- Day Typical Price 4.0
- Market Facilitation Index 0.74
- Price Action Indicator 0.37
- Period Momentum Indicator (0.01)
Market Snapshot Widget Example
DAX Index Germany | 19,426 0.85 | |
Taiwan Weighted Taiwan | 22,299 0.16 | |
PSI 20 Stock Portugal | 6,431 0.20 | |
CROBEX Croatia | 3,159 0.26 | |
Budapest SE Hungary | 78,374 0.83 | |
IDX 30 Jakarta Indonesia | 447.75 0.92 | |
ISEQ 20 Price Ireland | 1,594 0.58 | |
NYSE Comp USA | 20,210 0.05 | |
Tel Aviv 35 Israel | 2,260 0.72 | |
Coreshares Index Tracker South Afric | 1,106 1.00 | |
IPC MEXICO Mexico | 49,861 0.05 | |
KL Technology Malaysia | 58.73 1.56 | |
IBEX 35 Index Spain | 11,611 0.27 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,529 0.63 | |
SPASX Dividend Opportunities Australia | 1,696 0.33 | |
HNX 30 Vietnam | 474.27 0.32 | |
Bucharest BET-NG Romania | 1,209 0.20 | |
AMS Small Cap Netherlands | 1,215 3.41 | |
Oslo Exchange Mutual Norway | 1,413 0.06 | |
BEL Small Belgium | 8,045 0.09 | |
Basic Materials Brazil | 5,771 0.17 | |
Swiss Leader Price Switzerland | 1,929 0.49 | |
Fondo Mutuo ETF Chile | 1,362 0.28 | |
Athens General Comp Greece | 1,404 0.01 | |
Stock Exchange Of Thailand | 1,428 0.17 | |
PX Prague Stock Czech Repub | 1,689 0.35 | |
THE PHILIPPINE STOCK Philippines | 6,639 0.96 | |
WIG 30 Poland | 2,801 0.2 | |
BIST Electricity Turkey | 489.17 0.36 |
Investing Ideas
In addition to having Collplant Biotechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Collplant Biotechnologies
Compare Collplant Biotechnologies To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 0.06 | Quarterly Revenue Growth (0.98) | Return On Assets (0.34) | Return On Equity (0.62) |
The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.